Michael W. Wathen

2.2k total citations
44 papers, 1.9k citations indexed

About

Michael W. Wathen is a scholar working on Epidemiology, Genetics and Oncology. According to data from OpenAlex, Michael W. Wathen has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Michael W. Wathen's work include Herpesvirus Infections and Treatments (20 papers), Respiratory viral infections research (17 papers) and Cytomegalovirus and herpesvirus research (16 papers). Michael W. Wathen is often cited by papers focused on Herpesvirus Infections and Treatments (20 papers), Respiratory viral infections research (17 papers) and Cytomegalovirus and herpesvirus research (16 papers). Michael W. Wathen collaborates with scholars based in United States, Canada and Brazil. Michael W. Wathen's co-authors include Mark F. Stinski, Roger J. Brideau, D R Thomsen, Nancee L. Oien, Fred L. Homa, Mary L. Knechtel, Todd A. Hopkins, Patti R. Shaver, Leslie Tengelsen and Nels E. Pederson and has published in prestigious journals such as Biochemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Michael W. Wathen

44 papers receiving 1.7k citations

Peers

Michael W. Wathen

EPIDE

IMMUN

GENET

Masahiro Niikura Japan

Sheila Sturgill-Koszycki United States

Jeanne E. Burlein United States

J. H. E. T. Meuwissen Netherlands

Lucy F. Lee United States

Thierry Lang France

Susan T. Howard United States

Wai-Tsing Chan United States

Erwin Sablon Belgium

Joanna L. Miller United Kingdom

Masahiro Niikura Japan

Michael W. Wathen

997 ×0.6

EPIDE

400 ×1.0

269 ×0.8

IMMUN

691 ×2.4

186 ×0.8

GENET

Citations per year, relative to Michael W. Wathen Michael W. Wathen (= 1×) peers Masahiro Niikura

Countries citing papers authored by Michael W. Wathen

Since Specialization

Citations

This map shows the geographic impact of Michael W. Wathen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Wathen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Wathen more than expected).

Fields of papers citing papers by Michael W. Wathen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Wathen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Wathen. The network helps show where Michael W. Wathen may publish in the future.

Co-authorship network of co-authors of Michael W. Wathen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Wathen. A scholar is included among the top collaborators of Michael W. Wathen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Wathen. Michael W. Wathen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wathen, Michael W., Mario Barro, & Rick A. Bright. (2012). Antivirals in seasonal and pandemic influenza—future perspectives^*. Influenza and Other Respiratory Viruses. 7(s1). 76–80. 26 indexed citations

Nieman, James A., Sajiv K. Nair, Richard A. Nugent, et al.. (2010). Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 20(10). 3039–3042. 30 indexed citations

Tanis, Steven P., Joseph W. Strohbach, Suvit Thaisrivongs, et al.. (2010). The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase. Bioorganic & Medicinal Chemistry Letters. 20(6). 1994–2000. 15 indexed citations

Schnute, Mark E., Roger J. Brideau, Sarah A. Collier, et al.. (2008). Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition. Bioorganic & Medicinal Chemistry Letters. 18(14). 3856–3859. 18 indexed citations

Schnute, Mark E., David Anderson, Roger J. Brideau, et al.. (2007). 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases. Bioorganic & Medicinal Chemistry Letters. 17(12). 3349–3353. 36 indexed citations

Larsen, Scott D., Zhi‐Jun Zhang, Peter R. Manninen, et al.. (2007). 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase. Bioorganic & Medicinal Chemistry Letters. 17(14). 3840–3844. 8 indexed citations

Vaillancourt, Valerie, Roger J. Brideau, Mary L. Knechtel, et al.. (2000). Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase. Bioorganic & Medicinal Chemistry Letters. 10(18). 2079–2081. 23 indexed citations

Oien, Nancee L., et al.. (1994). Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Research. 34(3). 191–206. 83 indexed citations

Oien, Nancee L., Roger J. Brideau, Edward E. Walsh, & Michael W. Wathen. (1994). Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine. 12(8). 731–735. 46 indexed citations

10.

Wells, Peter A., et al.. (1994). Purification of a Recombinant Human Respiratory Syncytial Virus Chimeric Glycoprotein Using Reversed-Phase Chromatography and Protein Refolding in Guanidine Hydrochloride. Protein Expression and Purification. 5(4). 391–401. 1 indexed citations

11.

Homa, Fred L., et al.. (1993). Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. Journal of General Virology. 74(9). 1995–1999. 20 indexed citations

12.

Oien, Nancee L., Roger J. Brideau, D R Thomsen, Fred L. Homa, & Michael W. Wathen. (1993). Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity. Vaccine. 11(10). 1040–1048. 8 indexed citations

13.

Kakuk, Thomas J., Kenneth F. Soike, Roger J. Brideau, et al.. (1993). A Human Respiratory Syncytial Virus (RSV) Primate Model of Enhanced Pulmonary Pathology Induced with a Formalin-Inactivated RSV Vaccine but Not a Recombinant FG Subunit Vaccine. The Journal of Infectious Diseases. 167(3). 553–561. 80 indexed citations

14.

Brideau, Roger J. & Michael W. Wathen. (1991). A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice. Vaccine. 9(12). 863–864. 13 indexed citations

15.

Wathen, Michael W., Paul A. Aeed, & Åke P. Elhammer. (1991). Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9. Biochemistry. 30(11). 2863–2868. 37 indexed citations

16.

Wathen, Michael W., et al.. (1991). Vaccination of Cotton Rats with a Chimeric FG Glycoprotein of Human Respiratory Syncytial Virus Induces Minimal Pulmonary Pathology on Challenge. The Journal of Infectious Diseases. 163(3). 477–482. 42 indexed citations

17.

Brideau, Roger J., Rodney R. Walters, & Michael W. Wathen. (1989). Production, Characterization, and Utility of Monoclonal Antibodies Which React with a Novel Chimeric Glycoprotein of Human Respiratory Syncytial Virus Termed FG. Hybridoma. 8(6). 623–629. 2 indexed citations

18.

Wathen, Michael W., Roger J. Brideau, D R Thomsen, & Brian R. Murphy. (1989). Characterization of a Novel Human Respiratory Syncytial Virus Chimeric FG Glycoprotein Expressed Using a Baculovirus Vector. Journal of General Virology. 70(10). 2625–2635. 43 indexed citations

19.

Wathen, Michael W., Roger J. Brideau, & D R Thomsen. (1989). Immunization of Cotton Rats with the Human Respiratory Syncytial Virus F Glycoprotein Produced Using a Baculovirus Vector. The Journal of Infectious Diseases. 159(2). 255–264. 51 indexed citations

20.

Wathen, Michael W., et al.. (1986). Characterization and mapping of a nonessential pseudorabies virus glycoprotein. Journal of Virology. 58(1). 173–178. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact